450 related articles for article (PubMed ID: 32233054)
1. Predicting the Outcome of Transcatheter Arterial Embolization Therapy for Unresectable Hepatocellular Carcinoma Based on Radiomics of Preoperative Multiparameter MRI.
Sun Y; Bai H; Xia W; Wang D; Zhou B; Zhao X; Yang G; Xu L; Zhang W; Liu P; Xu J; Meng S; Liu R; Gao X
J Magn Reson Imaging; 2020 Oct; 52(4):1083-1090. PubMed ID: 32233054
[TBL] [Abstract][Full Text] [Related]
2. MRI-Based Radiomics: Associations With the Recurrence-Free Survival of Patients With Hepatocellular Carcinoma Treated With Conventional Transcatheter Arterial Chemoembolization.
Song W; Yu X; Guo D; Liu H; Tang Z; Liu X; Zhou J; Zhang H; Liu Y; Liu X
J Magn Reson Imaging; 2020 Aug; 52(2):461-473. PubMed ID: 31675174
[TBL] [Abstract][Full Text] [Related]
3. Radiomics Analysis Based on Multiparametric MRI for Predicting Early Recurrence in Hepatocellular Carcinoma After Partial Hepatectomy.
Zhao Y; Wu J; Zhang Q; Hua Z; Qi W; Wang N; Lin T; Sheng L; Cui D; Liu J; Song Q; Li X; Wu T; Guo Y; Cui J; Liu A
J Magn Reson Imaging; 2021 Apr; 53(4):1066-1079. PubMed ID: 33217114
[TBL] [Abstract][Full Text] [Related]
4. Prediction of tumor response via a pretreatment MRI radiomics-based nomogram in HCC treated with TACE.
Kong C; Zhao Z; Chen W; Lv X; Shu G; Ye M; Song J; Ying X; Weng Q; Weng W; Fang S; Chen M; Tu J; Ji J
Eur Radiol; 2021 Oct; 31(10):7500-7511. PubMed ID: 33860832
[TBL] [Abstract][Full Text] [Related]
5. Prognostic role of multiparameter MRI and radiomics in progression of advanced unresectable hepatocellular carcinoma following combined transcatheter arterial chemoembolization and lenvatinib therapy.
Luo J; Huang Z; Wang M; Li T; Huang J
BMC Gastroenterol; 2022 Mar; 22(1):108. PubMed ID: 35260095
[TBL] [Abstract][Full Text] [Related]
6. Prediction Model for Intermediate-Stage Hepatocellular Carcinoma Response to Transarterial Chemoembolization.
Jia F; Wu B; Yan R; Li L; Wang K; Han D
J Magn Reson Imaging; 2020 Dec; 52(6):1657-1667. PubMed ID: 32424881
[TBL] [Abstract][Full Text] [Related]
7. Computed tomography radiomic features and clinical factors predicting the response to first transarterial chemoembolization in intermediate-stage hepatocellular carcinoma.
Shi ZX; Li CF; Zhao LF; Sun ZQ; Cui LM; Xin YJ; Wang DQ; Kang TR; Jiang HJ
Hepatobiliary Pancreat Dis Int; 2024 Aug; 23(4):361-369. PubMed ID: 37429785
[TBL] [Abstract][Full Text] [Related]
8. [Prediction of short-term prognosis of hepatocellular carcinoma after TACE surgery based on MRI texture analysis technology].
Weng W; Lü XL; Zhang QQ; Zhao XM; Chen CM; Kong CL; Lu CY; Chen MJ; Ji JS
Zhonghua Yi Xue Za Zhi; 2020 Mar; 100(11):828-832. PubMed ID: 32234153
[No Abstract] [Full Text] [Related]
9. ADC
Wu L; Xu P; Rao S; Yang L; Chen C; Liu H; Fu C; Zeng M
J Magn Reson Imaging; 2017 Sep; 46(3):820-830. PubMed ID: 28276105
[TBL] [Abstract][Full Text] [Related]
10. Preoperative MRI features and clinical laboratory indicators for predicting the early therapeutic response of hepatocellular carcinoma to transcatheter arterial chemoembolization combined with High-intensity focused ultrasound treatment.
Zhang H; He X; Yu J; Song W; Liu X; Liu Y; Zhou J; Guo D
Br J Radiol; 2019 Jul; 92(1099):20190073. PubMed ID: 31166700
[TBL] [Abstract][Full Text] [Related]
11. MRI-Based Radiomics: Nomograms predicting the short-term response after transcatheter arterial chemoembolization (TACE) in hepatocellular carcinoma patients with diameter less than 5 cm.
Kuang Y; Li R; Jia P; Ye W; Zhou R; Zhu R; Wang J; Lin S; Pang P; Ji W
Abdom Radiol (NY); 2021 Aug; 46(8):3772-3789. PubMed ID: 33713159
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of efficacy of transcatheter arterial chemoembolization combined with computed tomography-guided radiofrequency ablation for hepatocellular carcinoma using magnetic resonance diffusion weighted imaging and computed tomography perfusion imaging: A prospective study.
Shao GL; Zheng JP; Guo LW; Chen YT; Zeng H; Yao Z
Medicine (Baltimore); 2017 Jan; 96(3):e5518. PubMed ID: 28099329
[TBL] [Abstract][Full Text] [Related]
13. MRI-Based Radiomics Signature: A Potential Biomarker for Identifying Glypican 3-Positive Hepatocellular Carcinoma.
Gu D; Xie Y; Wei J; Li W; Ye Z; Zhu Z; Tian J; Li X
J Magn Reson Imaging; 2020 Dec; 52(6):1679-1687. PubMed ID: 32491239
[TBL] [Abstract][Full Text] [Related]
14. A multi-institutional study to predict the benefits of DEB-TACE and molecular targeted agent sequential therapy in unresectable hepatocellular carcinoma using a radiological-clinical nomogram.
Liu K; Zheng X; Lu D; Tan Y; Hou C; Dai J; Shi W; Jiang B; Yao Y; Lu Y; Cao Q; Chen R; Zhang W; Xie J; Chen L; Jiang M; Zhang Z; Liu L; Liu J; Li J; Lv W; Wu X
Radiol Med; 2024 Jan; 129(1):14-28. PubMed ID: 37863847
[TBL] [Abstract][Full Text] [Related]
15. Development of a Novel Multiparametric MRI Radiomic Nomogram for Preoperative Evaluation of Early Recurrence in Resectable Pancreatic Cancer.
Tang TY; Li X; Zhang Q; Guo CX; Zhang XZ; Lao MY; Shen YN; Xiao WB; Ying SH; Sun K; Yu RS; Gao SL; Que RS; Chen W; Huang DB; Pang PP; Bai XL; Liang TB
J Magn Reson Imaging; 2020 Jul; 52(1):231-245. PubMed ID: 31867839
[TBL] [Abstract][Full Text] [Related]
16. MRI-Based Radiomics Signature for the Preoperative Prediction of Extracapsular Extension of Prostate Cancer.
Ma S; Xie H; Wang H; Han C; Yang J; Lin Z; Li Y; He Q; Wang R; Cui Y; Zhang X; Wang X
J Magn Reson Imaging; 2019 Dec; 50(6):1914-1925. PubMed ID: 31062459
[TBL] [Abstract][Full Text] [Related]
17. Radiomics Based on MRI as a Biomarker to Guide Therapy by Predicting Upgrading of Prostate Cancer From Biopsy to Radical Prostatectomy.
Zhang GM; Han YQ; Wei JW; Qi YF; Gu DS; Lei J; Yan WG; Xiao Y; Xue HD; Feng F; Sun H; Jin ZY; Tian J
J Magn Reson Imaging; 2020 Oct; 52(4):1239-1248. PubMed ID: 32181985
[TBL] [Abstract][Full Text] [Related]
18. Utility of volumetric contrast-enhanced and diffusion-weighted MRI in differentiating between common primary hypervascular liver tumors.
Zarghampour M; Fouladi DF; Pandey A; Ghasabeh MA; Pandey P; Varzaneh FN; Khoshpouri P; Shao N; Pan L; Grimm R; Kamel IR
J Magn Reson Imaging; 2018 Oct; 48(4):1080-1090. PubMed ID: 29630756
[TBL] [Abstract][Full Text] [Related]
19. Predicting the grade of hepatocellular carcinoma based on non-contrast-enhanced MRI radiomics signature.
Wu M; Tan H; Gao F; Hai J; Ning P; Chen J; Zhu S; Wang M; Dou S; Shi D
Eur Radiol; 2019 Jun; 29(6):2802-2811. PubMed ID: 30406313
[TBL] [Abstract][Full Text] [Related]
20. Radiomics Nomogram Building From Multiparametric MRI to Predict Grade in Patients With Glioma: A Cohort Study.
Wang Q; Li Q; Mi R; Ye H; Zhang H; Chen B; Li Y; Huang G; Xia J
J Magn Reson Imaging; 2019 Mar; 49(3):825-833. PubMed ID: 30260592
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
